Henan Taloph Pharmaceutical Stock Co. Ltd.SSE: 600222

2025 Semi-annual Report

Aug 27, 2025 · Issued by Henan Taloph Pharmaceutical Stock Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 27, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-15

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Henan Taloph Pharmaceutical Stock Co. Ltd. on 6ix

Earlier from Henan Taloph Pharmaceutical Stock

Announcement on Electing Employee Representative DirectorAug 16, 2025
Announcement on Election of Board of Directors at Expiry of Term of OfficeJul 31, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Jul 18, 2025
Announcement on Resolutions of the 32nd Meeting of the 9th Board of DirectorsJul 2, 2025
Announcement on Progress in Providing Guarantee for Financing of Holding SubsidiaryJun 13, 2025

Later from Henan Taloph Pharmaceutical Stock

Announcement on Completing Industrial and Commercial Change Registration of Legal RepresentativeAug 29, 2025
Announcement on Approval for Registration of Ultra-short-term Financing BondsSep 4, 2025
Announcement on Accepting the Guarantee from Indirect Controlling Shareholder and Paying Guarantee Fee as well as Related Party TransactionsSep 20, 2025
Announcement on Results of Issuing Phase I Ultra-Short-Term Financing Bonds of 2025Sep 26, 2025
Announcement on Progress in Receiving Financial Support from the Indirect Controlling Shareholder and Related Party TransactionSep 27, 2025

All Henan Taloph Pharmaceutical Stock news releases

Follow Henan Taloph Pharmaceutical Stock into a list and get an email when it puts out news.

Follow Henan Taloph Pharmaceutical Stock